Certara Inc. provides medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Certara Inc. is based in NJ, United States.
| Revenue (Most Recent Fiscal Year) | $418.84M |
| Net Income (Most Recent Fiscal Year) | $-1.60M |
| PE Ratio (Current Year Earnings Estimate) | 21.20 |
| PE Ratio (Trailing 12 Months) | 27.22 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.79 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.10 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 9.71 |
| Pre-Tax Margin (Trailing 12 Months) | 1.82% |
| Net Margin (Trailing 12 Months) | -0.38% |
| Return on Equity (Trailing 12 Months) | 4.20% |
| Return on Assets (Trailing 12 Months) | 2.90% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.05 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.05 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.27 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $6.67 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.05 |
| Earnings per Share (Most Recent Fiscal Year) | $0.28 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.01 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 159.14M |
| Free Float | 155.43M |
| Market Capitalization | $1.17B |
| Average Volume (Last 20 Days) | 3.33M |
| Beta (Past 60 Months) | 1.50 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.33% |
| Percentage Held By Institutions (Latest 13F Reports) | 73.96% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |